Skip to content
Cryptos: 553Market Cap: $2.87T 1.3%24h Vol: $129.14BDominance: BTC 58.1% ETH 10.5%
Open Tradzy

New high · Argentina stocks

Pfizer Inc. (PFE) closes at a 52-week high of ARS 11,780.00

Up 7.7% over 20 sessions. The previous highest close was ARS 11,660.00 on 28 Sept 2026.

Published 14 October 2026 · Written from Tradzy's price and volume data

Close
ARS 11,780.00
On the day
+3.3%
Volume
2.5× average
vs 52-week high
New high

Pfizer Inc. closing prices

ARS 9,000.00ARS 10,000.00ARS 11,000.00Jun '26Jul '26Jul '26Aug '26Sep '26Oct '26ARS 11,780.00

The last 90 closes up to 14 October 2026. The live chart is on the PFE page.

What happened

Pfizer Inc. (PFE) closed at ARS 11,780.00 on 14 October 2026, up 3.3% from ARS 11,400.00 the session before.

Over 5 sessions the price is up 6.6%, and over 20 sessions it is up 7.7%.

That close is above every close of the past year. The previous highest was ARS 11,660.00 on 28 Sept 2026, and the new close is 1.0% above it.

Trading was heavy: volume was 2.5 times its average of the sessions before.

Across the 21 BUENOSAIRES stocks we track, 10 closed higher and 11 closed lower that day, with a median change of −0.52%. PFE's change was +3.3%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeARS 11,400.00
CloseARS 11,780.00
Change on the day+3.33%
Change over 5 sessions+6.61%
Change over 20 sessions+7.68%
Volume39,755
Average volume, up to 20 sessions before16,037
Volume against that average2.5 times
Highest close in the past yearARS 11,660.00 (28 Sept 2026)
Lowest close in the past yearARS 8,890.00 (15 Oct 2025)

The full chart and history are on Pfizer Inc. (PFE). More from this market: BUENOSAIRES news today.

More BUENOSAIRES moves on 14 October 2026

Want a plan for PFE? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.